We are recruiting a postdoctoral fellow to work on mechanisms of systemic immune suppression during pregnancy and their application to the treatment of type 1 diabetes
The goal of our laboratory is to identify genes that regulate cancer stem cell self-renewal, differentiation, and chemoresistance in the hematopoietic system using primary patient material as well as mouse model systems. We primarily focus on hematologic cancers that arise from hematopoietic stem/progenitors cells such as acute myeloid leukemia and the myelodysplastic syndromes and strive to develop improved methods to diagnose, monitor, and treat patients.